Literature DB >> 20043464

Peripheral T-cell lymphomas: their time has come.

James O Armitage1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 20043464

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  2 in total

1.  Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Sophia S Wang; Christopher R Flowers; Marshall E Kadin; Ellen T Chang; Ann Maree Hughes; Stephen M Ansell; Andrew L Feldman; Tracy Lightfoot; Paolo Boffetta; Mads Melbye; Qing Lan; Joshua N Sampson; Lindsay M Morton; Yawei Zhang; Dennis D Weisenburger
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

2.  Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients.

Authors:  Yuanyuan Sun; Ling Li; Xin Li; Lei Zhang; Xinhua Wang; Xiaorui Fu; Zhenchang Sun; Xudong Zhang; Zhaoming Li; Jingjing Wu; Hui Yu; Yu Chang; Jiaqin Yan; Xiaolong Wu; Zhiyuan Zhou; Feifei Nan; Li Tian; Mingzhi Zhang
Journal:  Ther Adv Med Oncol       Date:  2020-05-27       Impact factor: 8.168
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.